Online Inquiry
Cat.#: ASSD-222
| Description | Antifade Fluorescence Mounting Medium from Ace Therapeutics with propidium iodide (hardset) is used to prevent the photobleaching of fluorescent proteins and dyes during fluorescent imaging. This product contains propidium iodide which is a widely used red-fluorescent intercalating agent that binds and labels nucleic acids. |
| Size | 10 mL |
| Applications | Cellular imaging, IHC(IF), ICC |
| Mounting | Aqueous (hardset) - cures in approximately 1 hour at room temperature |
| Antifade | Yes |
| Counterstain | Propidium Iodide |
| Refractive index | ≈1.45 (initial) which then increases to ≈1.518 once cured |
| Emission color | Red |
| Excitation | 535 nm |
| Emission | 617 nm |
| Closest laser lines | 532 nm |
| Cell permeable | Yes |
| Storage | +4°C or -20°C long-term. |
| Shipping | Shipped at 4°C |
| Important | If the mounting medium solidifies prematurely during operation, simply heat the bottle to approximately 60°C and the mounting medium will reliquefy. We strongly recommend storing this product in a storage buffer containing 0.05% sodium azide and away from light. |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-105 | Hoechst 33342 (AC105) | 10 mg, 100 mg | inquiry |
| ASSD-182 | 9-(2-Carboxy-2-cyanovinyl)julolidine (AC182) | 5 mg | inquiry |
| ASSD-147 | Rhodamine phalloidin-TRITC (AC147) | 300 tests, 100μg | inquiry |
| ASSD-200 | Ethylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[3-difluoromethyl-4-phosphoanilinamidosuccinic Acid] Diamide (AC200) | 500 μg | inquiry |
| ASSD-117 | Annexin V-PE Apoptosis Staining / Detection Kit (AC117) | 1 kit, 100 tests | inquiry |
| ASSD-202 | 5(6)-Carboxytetramethylrhodamine (AC202) | 100 mg, 250 mg | inquiry |
| ASSD-214 | 8-Aminopyrene-1,3,6-trisulfonic acid trisodium salt (AC214) | 10 mg | inquiry |
| ASSD-146 | Pyronin Y (AC146) | 1 g, 5g | inquiry |
| ASSD-141 | MTT (AC141) | 500 mg, 1 g | inquiry |
| ASSD-114 | Acridine Orange hydrochloride (AC114) | 50 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.